| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 6,000 | 6,200 | 09:20 |
| Stück | Geld | Kurs | Brief | Stück |
|---|---|---|---|---|
| 22,200 | 30 | |||
| 20,000 | 83 | |||
| 19,600 | 2 | |||
| 16,000 | 2.094 | |||
| 15,000 | 15 | |||
| 6,300 | 820 | |||
Quelle: [URL] https://aktienkurs-orderbuch.finanznachrichten.de/88q.htm [/URL] | ||||
| 820 | 6,000 | |||
| 450 | 5,300 | |||
| 1.061 | 0,001 | |||
| Summe Aktien im Kauf | Verhältnis | Summe Aktien im Verkauf | ||
| 2.331 | 1,306 | 3.044 | ||
| Uhrzeit | Aktienkurs | Stück |
|---|---|---|
Keine Umsätze verfügbar. | ||
| Tagesumsatz Xetra | - | 0 |
Angaben in grüner Schrift zeigen, dass der Aktienkurs im Vergleich zum vorherigen Kurs gestiegen ist. Angaben in roter Schrift zeigen gefallene Börsenkurse.
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 12.03. | IN BRIEF: 4basebio appoints Scott Lorimer as chief operating officer | 4 | Alliance News | ||
| 12.03. | 4basebio Plc - Appointment of COO | 331 | PR Newswire | 4basebio Plc - Appointment of COO
PR Newswire
LONDON, United Kingdom, March 12
THIS... ► Artikel lesen | |
| 09.03. | 4basebio promotes Christine Wolosin to chief commercial officer | 14 | Alliance News | ||
| 4BASEBIO Aktie jetzt für 0€ handeln | |||||
| 03.03. | 4basebio strengthens commercial leadership, promoting Christine Wolosin to Chief Commercial Officer | 234 | GlobeNewswire (Europe) | Seasoned biotechnology commercial leader will drive global growth strategy Commercial team further bolstered by promotions of James Vang and Jennifer Gelman to VP, Business Development and VP, Marketing... ► Artikel lesen | |
| 03.03. | 4basebio Plc - Appointment of CCO | 262 | PR Newswire | 4basebio Plc - Appointment of CCO
PR Newswire
LONDON, United Kingdom, March 03
THIS... ► Artikel lesen |
| Zeit | Aktuelle Nachrichten | Medien | ||
|---|---|---|---|---|
| Mo | Bio-Gate: Operativer Wendepunkt | Aktien-Global-Researchguide | Nach Darstellung der Analysten Matthias Greiffenberger und Cosmin Filker von GBC hat die Bio-Gate AG im ersten Halbjahr des Geschäftsjahres 2025 (per 31.12.) einen Umsatz von 3,44 Mio. Euro (HJ 2024:... ► Artikel lesen | |
| Mo | Aktie der Woche: Evotec Video | 4investors | Evotec ist unsere Aktie der Woche. Franziska Schimke und Markus Müller, Director Global Markets der ICF BANK AG, sprechen über die vorläufigen Zahlen und die Probleme beim Wissenschaftskonzern. Wie... ► Artikel lesen | |
| Mo | Galapagos NV: Galapagos and Gilead in Advanced Discussions to Collaborate on Advancing First in Class T Cell Engager Program for Autoimmune Diseases | GlobeNewswire (Europe) | Galapagos intends to enter into a strategic collaboration with Gilead following Gilead's acquisition of Ouro Medicines
New partnership structure would achieve meaningfully improved financial terms... ► Artikel lesen | |
| Mo | Trinity Biotech plc: Trinity Biotech Announces Successful Clinical Results for Its Enhanced EpiCapture Prostate Cancer Test | GlobeNewswire (Europe) | Test Now Incorporates Enhanced Machine Learning Risk Prediction Algorithm Plans Underway to Commercialise Testing Service Through Trinity Biotech's New York Reference Laboratory DUBLIN and NEW YORK... ► Artikel lesen | |
| Mo | Novonesis (Novozymes A/S): Resolutions from the Annual General Meeting 2026 | GlobeNewswire (Europe) | Today, the Annual General Meeting of Novonesis (Novozymes A/S) was conducted. The following resolutions were made: Approval of the audited Annual Report for 2025Approval of distribution of profit... ► Artikel lesen |